Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - comparison of pharmacology and clinical efficacy

by Pletz Mathias W, Burkhardt Olaf, Welte Tobias
Published 2010-11-01

Severe pneumococcal pneumonia following Measles- Mumps- Rubella vaccination / Pneumonie pneumococică severă dezvoltată ca urmare a vaccinării Rujeolă-Oreion-Rubeolă

by Gál Orsolya, Pletz Mathias W., Ianoși Edith Simona
Published 2016-09-01

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

by Egerer Gerlinde, Reichert Dietmar, Pletz Mathias W, Kaskel Peter, Krobot Karl J, Maertens Johan
Published 2012-04-01

Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from th...

by Zobel Katrin, Martus Peter, Pletz Mathias W, Ewig Santiago, Prediger Michael, Welte Tobias, Bühling Frank
Published 2012-02-01

Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study

by Kolditz Martin, Höffken Gert, Martus Peter, Rohde Gernot, Schütte Hartwig, Bals Robert, Suttorp Norbert, Pletz Mathias W
Published 2012-04-01

Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Respiratorische Infektionen

by Ott, Sebastian R., Bodmann, Klaus-Friedrich, Grabein, Béatrice, Höffken, Gert, Kolditz, Martin, Lode, Hartmut, Pletz, Mathias W., Thalhammer, Florian
Published 2020-03-01

Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin – a retrospective analysis of medical charts and re-imbursement data of real-life patient...

by Wilke, Michael H., Becker, Karsten, Kloss, Sebastian, Heimann, Sebastian M., Goldmann, Anton, Weber, Bertram, Pletz, Mathias W., Simon, Philipp, Petrik, Christian
Published 2017-01-01

Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections

by Kresken, Michael, von Müller, Lutz, Grabein, Béatrice, Herrmann, Mathias, Höffken, Gert, Hoerauf, Achim, Kern, Peter, Pletz, Mathias W., Reisinger, Emil, Cornely, Oliver A., Groll, Andreas H.
Published 2013-11-01